Creation of SkinBiotherapeutics PLC

  • Catherine O'Neill (Corresponding participant)
  • Mcbain, Andrew (Participant)

Impact: Economic, Health and wellbeing


In March 2016, a technology created from basic science research within my laboratory was spun out into a commercial vehicle called Skinbiotix ltd. In April 2017, Skinbiotix Ltd was floated on the AIM market of the London stock exchange and became SkinBioTherapeutics plc. The company now employs 4 people and is developing the technology into products.
Impact date2012
Category of impactEconomic, Health and wellbeing
Impact levelBenefit